Clinical studies identified strong positive correlations between A-FABP, insulin resistance, and type 2 diabetes [17,18,22,65,66,67,79,80,81,82], suggesting A-FABP as a biomarker of insulin resistance. Here, FABP4 is linked to type 2 diabetes mellitus.